Topiramate
Product Images NDC 70934-768

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70934-768). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 768 30 Master Bottle Label Approval Rev A 01 21)

This is a medication description for Topiramate Tablets, USP, with a strength of 100mg and a quantity of 30 tablets. The NDC number for the product is 70934-768-30. The rest of the text is not readable.*

FDA Label Image

Structured Product Formula For Topiramate (Dc0a034e Df8a 4de6 Be65 82ebf72ddb48 01)

FDA Label Image

Structured Product Formula For Topiramate (Dc0a034e Df8a 4de6 Be65 82ebf72ddb48 02)

This is a graph showing the cumulative rates of time to the first seizure in patients taking two different doses of topiramate (50mg/day and 400mg/day). The graph shows that the higher dose (400mg/day) results in a significantly lower rate of first seizures compared to the lower dose (50mg/day). The graph is labeled with time in days and dosage in milligrams.*

FDA Label Image

Topiramate Tablets Usp (Dc0a034e Df8a 4de6 Be65 82ebf72ddb48 03)

This text shows the change in the average monthly migraine period rate from the baseline phase to the double-blind phase of a study involving topiramate at different doses and a placebo. The results are presented in a table format showing the sample sizes and p-values for each treatment group.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.